Arkolith/Insider Trading/HCWB/Form 4

Byam Rebecca

Chief Financial OfficerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed May 9, 2025
Net Buying
Open-Market Buys
$220K
Open-Market Sells
$0
Net Open-Market Flow
$220K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2025Buy(P)8K$26.00$220K43K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2025Buy(P)4K—$04K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-068281) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML